Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immune-cognitive relationships across viral infections: A transnosological systematic review.

Neuroscience and biobehavioral reviews·2026
Same author

Patient-reported outcomes as predictors of disability evolution in Multiple Sclerosis: An interpretable machine learning approach.

Multiple sclerosis (Houndmills, Basingstoke, England)·2026
Same author

The Inflammatory Side of Iatrogenic Cerebral Amyloid Angiopathy: Rethinking Therapeutic Opportunities.

Brain sciences·2026
Same author

Miglustat in Alzheimer's Disease Associated With Heterozygous NPC1 Mutation: Exploratory Case Series and Preliminary Findings.

European journal of neurology·2025
Same author

Inflammatory predictors of Post-COVID fatigue.

Brain, behavior, & immunity - health·2025
Same author

Perampanel effects on seizures and sleep quality in people with epilepsy: A prospective multicenter study.

Epilepsy & behavior : E&B·2025
Same journal

Intrahepatic cholangiocarcinoma treated with glass yttrium-90 radioembolization: A histopathologic study.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Novel PET tracers to distinguish the nature of residual masses after the completion of chemotherapy in metastatic testicular germ cell tumours: A systematic review.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Diagnostic impact of 18F-FDG PET/MRI over PET/CT in histiocytoses: a prospective comparative study.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Insights from an unfortunate FDG contamination.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Clinical performance of [<sup>68</sup>Ga]Ga-DOTA-FAPI-04 PET/CT in detecting recurrent disease in medullary thyroid carcinoma: a comparative analysis with [<sup>18</sup>F]F-FDG and [<sup>68</sup>Ga]Ga-DOTATATE PET/CT, alongside identification of suitable candidates for targeted radionuclide therapy.

European journal of nuclear medicine and molecular imaging·2026
Same journal

Whole-brain metabolic activity on pretreatment [18 F]FDG PET/CT provides prognostic information beyond metabolic tumour burden in patients with breast cancer.

European journal of nuclear medicine and molecular imaging·2026
See all related articles

Related Experiment Video

Updated: Dec 30, 2025

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.5K

A kinetics-based approach to amyloid PET semi-quantification.

A Chincarini1, E Peira2,3, M Corosu2

  • 1Istituto Nazionale di Fisica Nucleare (INFN), via Dodecaneso 33, I-16146, Genova, Italy. andrea.chincarini@ge.infn.it.

European Journal of Nuclear Medicine and Molecular Imaging
|January 27, 2020
PubMed
Summary
This summary is machine-generated.

A new time-delayed ratio (TD r) method for amyloid PET scans offers a validated, accurate alternative for semi-quantification. This approach simplifies analysis, requiring only two scans and no MRI registration, making it efficient for clinical use.

Keywords:
Amyloid PETFluorinated tracerSemi-quantificationTracer kinetics

More Related Videos

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.9K

Related Experiment Videos

Last Updated: Dec 30, 2025

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections
07:28

Full- versus Sub-Regional Quantification of Amyloid-Beta Load on Mouse Brain Sections

Published on: May 19, 2022

4.5K
Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease
09:33

Quantitative 3D In Silico Modeling q3DISM of Cerebral Amyloid-beta Phagocytosis in Rodent Models of Alzheimer's Disease

Published on: December 26, 2016

8.3K
Detecting Amyloid-&#946; Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease
08:25

Detecting Amyloid-β Accumulation via Immunofluorescent Staining in a Mouse Model of Alzheimer's Disease

Published on: April 19, 2021

3.9K

Area of Science:

  • Nuclear Medicine
  • Neuroimaging
  • Radiochemistry

Background:

  • Amyloid PET imaging is crucial for diagnosing Alzheimer's disease.
  • Accurate semi-quantification methods are needed to standardize interpretation of amyloid PET scans.
  • Existing methods like SUVr and ELBA have limitations in processing or data requirements.

Purpose of the Study:

  • To develop and validate a novel semi-quantification method, the time-delayed ratio (TD r), for amyloid PET scans.
  • To assess the performance of TD r using tracer kinetics information.
  • To compare TD r with existing visual and semi-quantitative methods.

Main Methods:

  • The TD r method utilizes two static PET scans: an early scan (0-10 min) and a late scan (50-100 min).
  • High perfusion regions from the early scan are applied to the late scan to calculate a ratio.
  • TD r was applied to a multicenter dataset of 143 subjects using [18F]florbetapir and compared to visual assessment, SUVr, and ELBA.

Main Results:

  • TD r demonstrated excellent agreement with visual assessment (AUC = 0.99).
  • TD r significantly correlated with validated methods, showing a Pearson correlation of 0.86 with ELBA.
  • The method proved robust across a heterogeneous dataset.

Conclusions:

  • TD r provides a reliable alternative semi-quantification method for amyloid PET imaging.
  • It requires minimal image processing, no predefined regions of interest, and no MRI registration.
  • The method leverages readily available early scans with negligible added patient burden.